Immunogenicity and Safety of a Measles-Mumps-Rubella Vaccine Administered as a First Dose to Children Aged 12 to 15 Months: A Phase III, Randomized, Noninferiority, Lot-to-Lot Consistency Study.

Name: Immunogenicity and Safety of a Measles-Mumps-Rubella Vaccine Administered as a First Dose to Children Aged 12 to 15 Months: A Phase III, Randomized, Noninferiority, Lot-to-Lot Consistency Study.
Author: Klein, Nicola P

Immunogenicity and Safety of a Measles-Mumps-Rubella Vaccine Administered as a First Dose to Children Aged 12 to 15 Months: A Phase III, Randomized, Noninferiority, Lot-to-Lot Consistency Study. — المؤلف: Klein, Nicola P — Journal of the Pediatric Infectious Diseases Society 20201204

المؤلف: Klein, Nicola P
النشر: Journal of the Pediatric Infectious Diseases Society 20201204
الوصف: 194-201 p.
الموضوعات: Antibodies, Viral؛ Enzyme-Linked Immunosorbent Assay؛ Exanthema؛ Female؛ Fever؛ Government Regulation؛ Humans؛ Infant